Hai Liu

Publication Activity (10 Years)

Years Active: 2019-2021
Publications (10 Years): 6

Top Topics

Diabetic Retinopathy

Long Noncoding Rna

Induced Pluripotent Stem Cells

Top Venues

Drug design, development and therapy

Food & function

Future medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Jianqiong Yang, Ling Cao, Yamei Li, Hai Liu, Minhong Zhang, Huamou Ma, Biao Wang, Xiaoliang Yuan, Qian Liu
Gracillin Isolated from Reineckia carnea Induces Apoptosis of A549 Cells via the Mitochondrial Pathway. Drug design, development and therapy 15 (2021)
Yizhou Zheng, Rui Zhang, Weimei Shi, Linfu Li, Hai Liu, Zhixi Chen, Longhuo Wu
Metabolism and pharmacological activities of the natural health-benefiting compound diosmin. Food & function 11 (10) (2021)
Hao Huang, Yizhou Zheng, Linfu Li, Weimei Shi, Rui Zhang, Hai Liu, Zhixi Chen, Longhuo Wu
The roles of post-translational modifications and coactivators of STAT6 signaling in tumor growth and progression. Future medicinal chemistry 12 (21) (2020)
Hai Liu, Jianqiong Yang, Wanqing Yang, Shaonan Hu, Yali Wu, Bo Zhao, Haiyan Hu, Shouying Du
Focus on Notoginsenoside R1 in Metabolism and Prevention Against Human Diseases. Drug design, development and therapy 14 (2020)
Xiaohua Guo, Zhaowen Liu, Yizhou Zheng, Yamei Li, Linfu Li, Hai Liu, Zhixi Chen, Longhuo Wu
Review on the Structures and Activities of Transthyretin Amyloidogenesis Inhibitors. Drug design, development and therapy 14 (2020)
Xianhua Huang, Zhixi Chen, Weimei Shi, Rui Zhang, Linfu Li, Hai Liu, Longhuo Wu
TMF inhibits miR-29a/Wnt/β-catenin signaling through upregulating Foxo3a activity in osteoarthritis chondrocytes. Drug design, development and therapy 13 (2019)